Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 months
Indian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs in the coming months. Approximately fifteen companies are expected to enter the primary market, with fertility and women's health segments particularly in (...)
Site référencé: The Economic Times
The Economic Times
Sept-end listing deadline looms large for Tata Sons
29/09/2025
Two-thirds of Nifty 500 stocks trade below last year’s levels
29/09/2025
Will India-US tariff deal spark the next rally on Dalal Street ?
29/09/2025
IPO boom defies market slump, mobilises nearly Rs 1.7 lakh crore in a year
29/09/2025
Laser Power & Infra, Indo MIM files draft papers with Sebi for IPOs
28/09/2025
Ahead of Market : 10 things that will decide stock market action on Monday
28/09/2025
